Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 14, 2020; 26(38): 5874-5883
Published online Oct 14, 2020. doi: 10.3748/wjg.v26.i38.5874
Published online Oct 14, 2020. doi: 10.3748/wjg.v26.i38.5874
Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study
Arantza Sanvisens, Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona 08916, Spain
Inmaculada Rivas, Eva Faure, Néstor Espinach, Mental Health and Addiction Service, Badalona Serveis Assistencials-BSA, Badalona 08911, Spain
Anna Hernandez-Rubio, Robert Muga, Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona 08916, Spain
Xavier Majó, Joan Colom, Program on HIV, STIs and Viral Hepatitis - PCAVIHV Public Health Agency of Catalonia, Generalitat de Catalunya, Barcelona 08005, Spain
Author contributions: Sanvisens A and Muga R designed the study and wrote the first draft of the manuscript; Sanvisens A managed the literature searches and statistical analysis; Rivas I, Faure E, Espinach N, and Hernandez-Rubio A recruited the study population and took care of patients; Sanvisens A, Rivas I, Majó X, Colom J and Muga R reviewed the literature and made contributions to the interpretation of data; and all the authors contributed to the discussion section and revised and approved the final manuscript.
Supported by the Ministry of Science , Innovation and Universities, Carlos III Health Institute (ISCIII), European Fund for Regional Development (FEDER), Network for Cooperative Research in Health (RETICS), Spain (No. RD16/0017/0003, PI17/00174, INT19/00026, CD19/00019) ; the Ministry of Health , National Plan on Drugs (PNSD), Spain (No. 2018/020) ; the European Commission (806996-JUSTSO-JUST2017-AG-DRUG) ; the Gilead Fellowship Program , Gilead Sciences (No. GLD17/187) ; the Ministry of Education , Spain (No. PRX18/00245) ; the Agency for Management of University and Research Grants , Government of Catalonia (No. 2017SGR316) ; and the Municipal Institute of Personal Services-IMSP, Badalona .
Institutional review board statement: The study was reviewed and approved by the Ethics Committee of the Hospital Universitari Germans Trias i Pujol (PI-15-100), Badalona, Spain.
Informed consent statement: All study participants, or their legal guardian, provided written consent prior to study enrollment.
Conflict-of-interest statement: The authors of this manuscript having no conflicts of interest to disclose.
Data sharing statement: There is no additional data available.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Robert Muga, MD, PhD, Professor, Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Ctra. canyet s/n, Badalona 08916, Spain. rmuga.germanstrias@gencat.cat
Received: June 9, 2020
Peer-review started: June 9, 2020
First decision: July 29, 2020
Revised: August 12, 2020
Accepted: September 17, 2020
Article in press: September 17, 2020
Published online: October 14, 2020
Processing time: 127 Days and 1.5 Hours
Peer-review started: June 9, 2020
First decision: July 29, 2020
Revised: August 12, 2020
Accepted: September 17, 2020
Article in press: September 17, 2020
Published online: October 14, 2020
Processing time: 127 Days and 1.5 Hours
Core Tip
Core Tip: Longitudinal study carried out in the only Opioid Treatment Program authorized for the provision of methadone or buprenorphine in a large urban area of 360000 inhabitants. Results indicate that hepatitis C virus treatment rates are increasing since the introduction of direct antiviral agents and identifies gaps and challenges on the readiness to treat infection.